NanoViricides Inc. (NNVC)

[crashco]

The question posed is based on a false premise. NanoViricides did not determine that a whole new production process was required.
Not that it is relevant to your false premise but there is a wonderful silver lining in the grey cloud of Tox delay. In informal Tox studies conducted by Kard it was determined that FluCide was so very non toxic therefore vastly greater volumes of FluCide were determined to be required for BASI formal Tox testing.
Incidentally, materials for the formal round of Tox testing are being generated in NanoViricides existing facility to optimized and lab validated specs. Further, manufacturing scale up processes, in the existing facility, indicate that Shelton facility scale up activities will proceed with little or no challenge.

NanoViricides will complete Tox studies for FluCide in 2014.